title: Drug-eluting stents.
abstract: Drug-eluting stents are designed to reduce the risk of major adverse cardiac events after percutaneous coronary intervention by inhibiting cellular proliferation and reducing restenosis of the coronary artery. In high-risk lesions, drug-eluting stents may limit restenosis and the need for repeat revascularization. In optimal lesions, they may eliminate restenosis completely. Drug-eluting stents have made percutaneous intervention a safe and definitive treatment for coronary artery disease.
authors.affiliation: Interventional Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Desk F25, 9500 Euclid Avenue, Cleveland, OH 44195, USA. whitlop@ccf.org
authors.forename: Patrick
authors.initials: P
authors.lastname: Whitlow
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000628:therapy*; D023903:Coronary Restenosis / Q000517:prevention & control; D003925:Diabetic Angiopathies / Q000628:therapy; D054855:Drug-Eluting Stents; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D017239:Paclitaxel / Q000008:administration & dosage*; D020123:Sirolimus / Q000008:administration & dosage
chemical_list: D007166:Immunosuppressive Agents; D017239:Paclitaxel; D020123:Sirolimus